Abbott
At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.
Business & Industry
- Roche's first FDA-approved tumour-agnostic medicine
- Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer
- Boehringer Ingelheim and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies
- Lilly, Evidation Health and Apple study shows personal digital devices may help in the identification of mild cognitive impairment and mild Alzheimer's disease dementia
- Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
Research & Development
- Drug accelerates blood system's recovery after chemotherapy, radiation
- New drug shows encouraging survival in pancreatic cancer
- Ancient natural history of antibiotic production and resistance revealed
- Eating more plant-based foods may be linked to better heart health
- Rye is healthy, thanks to an interplay of microbes
- Closing the door: breaking new ground related to a potential anticancer drug target
- Leading oncologists and nutritionists pinpoint areas to catalyze nutrition-based cancer prevention
Conferences & Events
- Respiratory Drug Delivery 2019
- Exclusive iVeena speaker interview released for 3rd Ophthalmic Drugs Conference
- eyeforpharma The Marketing Disruption Summit
- Optima to host post-conference workshop at Lyophilization USA
- The need for a blueprint emergency plan to avoid a HPAPI crisis
- Ophthalmic Drugs Conference 2019
- Lyophilization USA Conference 2019
Regulatory Affairs
- FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs
- FDA approves first therapy for rare joint tumor
- FDA approves first treatment for severe hypoglycemia that can be administered without an injection
- FDA approves first generics of Lyrica
- FDA approves new treatment for refractory multiple myeloma